Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas B Stairs

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Cancer Growth and Metastasis|September 19, 2015
Single and Multiple Gene Manipulations in Mouse Models of Human CancerHeather L Lehman, Douglas B Stairs
Scientific Reports|November 3, 2020
Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytesHeather L Lehman, Michal Kidacki, Douglas B Stairs
Biochemical Society Transactions|March 20, 2010
Modelling Barrett's oesophagusJianping Kong, Douglas B Stairs, John P Lynch
Progress in Molecular Biology and Translational Science|November 16, 2010
Cdx genes, inflammation, and the pathogenesis of intestinal metaplasiaDouglas B Stairs, Jianping Kong, John P Lynch
Transgenic Research|November 30, 2005
The serine/threonine kinase, Krct, affects endbud morphogenesis during murine mammary gland developmentDouglas B Stairs, Kathleen L Notarfrancesco, Lewis A Chodosh
Pathology Research International|June 16, 2012
Barrett's Esophagus: Emerging Knowledge and Management StrategiesAtul Bhardwaj, Thomas J McGarrity, Douglas B Stairs, et al.
Oncotarget|March 16, 2018
NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulationHeather L Lehman, Michal Kidacki, Joshua I Warrick, et al.
The American Journal of Pathology|December 23, 2014
p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinomaHeather L Lehman, Xuebin Yang, Patricia A Welsh, et al.
Pathology, Research and Practice|January 10, 2025
Histological features indicate the risk of progression of patients with Barrett's esophagusTiane Chen, Hong Ly, Douglas B Stairs, et al.
Current Cancer Drug Targets|February 5, 2016
Proteomic and Metabolic Signatures of Esophageal Squamous Cell CarcinomaKubra Karagoz, Heather L Lehman, Douglas B Stairs, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cancer Growth and Metastasis|September 19, 2015
Single and Multiple Gene Manipulations in Mouse Models of Human CancerHeather L Lehman, Douglas B Stairs
Scientific Reports|November 3, 2020
Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytesHeather L Lehman, Michal Kidacki, Douglas B Stairs
Biochemical Society Transactions|March 20, 2010
Modelling Barrett's oesophagusJianping Kong, Douglas B Stairs, John P Lynch
Progress in Molecular Biology and Translational Science|November 16, 2010
Cdx genes, inflammation, and the pathogenesis of intestinal metaplasiaDouglas B Stairs, Jianping Kong, John P Lynch
Transgenic Research|November 30, 2005
The serine/threonine kinase, Krct, affects endbud morphogenesis during murine mammary gland developmentDouglas B Stairs, Kathleen L Notarfrancesco, Lewis A Chodosh
Pathology Research International|June 16, 2012
Barrett's Esophagus: Emerging Knowledge and Management StrategiesAtul Bhardwaj, Thomas J McGarrity, Douglas B Stairs, et al.
Oncotarget|March 16, 2018
NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulationHeather L Lehman, Michal Kidacki, Joshua I Warrick, et al.
The American Journal of Pathology|December 23, 2014
p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinomaHeather L Lehman, Xuebin Yang, Patricia A Welsh, et al.
Pathology, Research and Practice|January 10, 2025
Histological features indicate the risk of progression of patients with Barrett's esophagusTiane Chen, Hong Ly, Douglas B Stairs, et al.
Current Cancer Drug Targets|February 5, 2016
Proteomic and Metabolic Signatures of Esophageal Squamous Cell CarcinomaKubra Karagoz, Heather L Lehman, Douglas B Stairs, et al.
Pageof 4